Clinical trial
A Proof of Concept Randomized Controlled Trial of XEN1101 for the Treatment of Major Depressive Disorder
NCT04827901 is registered in ClinicalTrials.gov with James Murrough as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Proof of Concept Randomized Controlled Trial of XEN1101 for the Treatment of Major Depressive Disorder
- Lead sponsor
- James Murrough
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 19, 2021
- Completion date
- November 7, 2024
- Enrollment
- 44 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.